Rhythm Pharmaceuticals, Inc. (RYTM)
Market: NASD |
Currency: USD
Address: 222 Berkeley Street
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Show more
📈 Rhythm Pharmaceuticals, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$83.42
-
Upside/Downside from Analyst Target:
35.68%
-
Broker Call:
24
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
25-50%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Rhythm Pharmaceuticals, Inc.
| Date | Reported EPS |
|---|
| 2026-05-05 (estimated upcoming) | - |
| 2026-02-24 (estimated upcoming) | - |
| 2025-11-03 (estimated upcoming) | - |
| 2025-11-02 (estimated upcoming) | - |
| 2025-08-04 (estimated upcoming) | - |
| 2025-08-03 (estimated upcoming) | - |
| 2025-05-07 | -0.81 |
| 2025-05-04 | - |
| 2025-02-26 | -0.72 |
| 2025-01-10 | - |
| 2024-11-05 | -0.73 |
| 2024-08-06 | -0.69 |
| 2024-08-05 | -0.69 |
| 2024-05-07 | -2.35 |
| 2024-05-06 | -2.35 |
| 2024-02-22 | -0.7 |
| 2024-02-21 | -0.7 |
| 2023-11-07 | -0.76 |
| 2023-11-06 | -0.76 |
| 2023-08-01 | -0.82 |
| 2023-07-31 | -0.82 |
| 2023-05-02 | -0.92 |
| 2023-05-01 | -0.92 |
| 2023-03-01 | -0.75 |
| 2023-02-28 | -0.75 |
| 2022-11-08 | -0.79 |
| 2022-11-07 | -0.79 |
| 2022-08-02 | -0.89 |
| 2022-08-01 | -0.89 |
| 2022-05-03 | -1.05 |
| 2022-05-02 | -1.05 |
| 2022-03-01 | -0.85 |
| 2022-02-28 | -0.85 |
| 2021-11-02 | -0.7 |
| 2021-11-01 | -0.7 |
| 2021-08-03 | -0.7 |
| 2021-08-02 | -0.7 |
| 2021-05-03 | -1.16 |
| 2021-05-02 | -1.16 |
| 2021-03-01 | -0.79 |
| 2021-02-28 | -0.79 |
| 2020-11-02 | -0.77 |
| 2020-11-01 | -0.77 |
| 2020-08-03 | -0.71 |
| 2020-08-02 | -0.71 |
| 2020-05-04 | -0.78 |
| 2020-05-03 | -0.78 |
| 2020-03-01 | -0.78 |
| 2019-10-31 | -1.04 |
| 2019-07-28 | -1.24 |
| 2019-05-02 | -0.84 |
| 2019-03-07 | -0.74 |
| 2018-11-08 | -0.52 |
| 2018-08-07 | -0.52 |
| 2018-05-13 | -0.6 |
| 2018-03-11 | -0.41 |
| 2017-11-13 | -1.51 |
| 2017-10-04 | - |
📰 Related News & Research
No related articles found for "rhythm pharmaceuticals".
